Skip to main content

Slynd FDA Approval History

Last updated by Judith Stewart, BPharm on July 1, 2019.

FDA Approved: Yes (First approved May 23, 2019)
Brand name: Slynd
Generic name: drospirenone
Dosage form: Tablets
Company: Exeltis
Treatment for: Birth Control

Slynd (drospirenone) is a progestin oral contraceptive for birth control.

Development timeline for Slynd

Jun  6, 2019Approval Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
Nov 29, 2018FDA Accepts Filing of New Estrogen-free Oral Contraceptive Slinda (drospirenone) Developed by Exeltis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.